Navigation Links
Egg donation: The way to happy motherhood, with risks and side effects
Date:1/24/2011

Women who have become pregnant after egg donation should be categorized as high-risk patients. Why that is the case, and which consequences egg donation may have for women is the subject of a review article by Ulrich Pecks and co-authors from the University Hospital Aachen in the current issue of Deutsches rzteblatt International (Dtsch Arztebl In 2011; 108[3]: 23-31).

The authors support their assessment with data from recent publications and with a case series they encountered in their own hospital. Viewing patient files they found that within the past 4 years, 8 women who had received donated eggs had to be treated for pregnancy-induced hypertension. Three of these pregnancies had to be terminated prematurely because of the threat to the mother's life. The other 5 cases showed a milder course of pregnancy-induced hypertension.

Egg donation has been in use for more than 25 years to treat unwanted childlessness. Since the German law on the protection of embryos explicitly forbids the procedure, couples often use medical institutions in neighboring European countries. After successful embryo transfer, the pregnant women are subsequently cared for in Germany in accordance with statutory maternity provision. Because of the risk of a hypertensive disorder of pregnancy, the authors recommend that the patients are closely monitored by doctors with a specialization in maternofetal medicine.


'/>"/>

Contact: Dr. Ulrich Pecks
upecks@ukaachen.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. A happy new year for penguins
2. Happy flies look for a place like home
3. Happy holidays from the groaning board; Western diets turn on fat genes
4. 6 environmental research studies reveal critical health risks from plastic
5. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases
6. Vitamin D deficiency in infants and nursing mothers carries long-term disease risks
7. More freedom to take risks: DFG funds the first Reinhart Koselleck Projects
8. Athletes not spared from health risks of metabolic syndrome
9. New insights into a leading poultry disease and its risks to human health
10. Rice eyes risks of quantum dots
11. Newly described contaminant sources in Katrina-flooded homes pose health risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... Chine, 31 juillet 2015 La 10e ... ) sera organisée par le BGI du 22 ... en Chine. La conférence ... inauguration en 2006, l,ICG est devenue l,une des ... domaine des « omiques » et c,est aussi la plus ...
(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... faced with everyday obstacles in their physical environments and ... with them. Navigating these obstacles can involve highly complex ... work, researchers have employed an ingenious obstacle-based system for ... in the fruit fly Drosophila. , The findings ...
... tailored therapiesContinuing its strong support for studies on ... Institutes of Health anticipates spending more than $150 ... Research Network (PGRN). The research of this nationwide ... drug prescriptions to people's unique genetic make-ups. ...
... have found a family of proteins that enhances the sensitivity ... growth and cancer. Their discovery could lead to a completely ... new drugs to stop uncontrolled growth in a wide variety ... Oxford, funded in part by the Biotechnology and Biological Sciences ...
Cached Biology News:Gap-climbing fruit flies reveal components of goal-driven behaviors 2NIH renews network focused on how genes influence drug responses 2NIH renews network focused on how genes influence drug responses 3NIH renews network focused on how genes influence drug responses 4Fruit fly studies open new window on cancer research 2
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... announced that the 30-day review period following the ... for ocular indications with the U.S. Food and ... is now active. Logo -  ...
(Date:8/31/2015)... 31, 2015 FLX Bio, Inc., a biopharmaceutical ... cancer immunotherapies, announced today that it has appointed ... and William Ho , M.D., Ph.D., as Chief ... management team led by veterans of Flexus Biosciences, Inc., ... Scientific Officer; Jay Powers , Ph.D., Vice President, ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... as a high priority in the drug development approval process. Thus, innovator companies ... This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple educational ...
(Date:8/31/2015)... ... ... Proove Biosciences, Inc. is a finalist for the Outstanding Tech Company category of ... its 22nd year, this premier awards event celebrates the best in Orange County’s technology ... world. The OC Tech Alliance will announce all winners at a gala dinner on ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4
... ground-breaking treatment option for victims of whiplash associated disorders (WAD). ... Z Therapy is the first and only rehabilitation specialist in North ... neck pain. , ... Dallas, TX (PRWEB) April 21, ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the first quarter ... before the opening of the financial markets.NxStage will also ... on Friday, May 8, 2009 to discuss its first ...
... LLC announced today that it has issued an Executive ... 56-page report can be found at www.crystalra.com ... is a closely held pharmaceutical company focused exclusively on ... a technology spinout from Bayer HealthCare LLC, ACT Biotech ...
Cached Biology Technology:Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers 2NxStage to Report First Quarter 2009 Financial Results 2Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 2Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 3
... Peptide sequences: Two separate vials ... to the same sequence used as ... (Catalog No. 160890) ... Cayman's guanylate cyclase polyclonal antiserum (Catalog ...
... 3B8A10. Immunogen: Recombinant ... C-terminal region of human ... for the human ubiquilin ... (positive control: 293 cells). ...
... PinPoint™ Vector Sequencing Primer is designed for ... Vectors (Cat.# V2031, V2051, V2061). The primer ... at nucleotides 325343, approximately 4050 base pairs ... can be used to determine if an ...
... The versatile Zymo-Spin I-96 Plate can be ... manifolds for the large-scale (i.e., 96-well) purification ... polypropylene construction and unique silica-based matrix make ... g DNA or RNA in = 10 ...
Biology Products: